Showing results (1-10 of 68) with videos related to
Sort By:
Pageof 7
Neurochemistry International|November 26, 2009
L-DOPA-induced 6-hydroxydopamine production in the striata of rodents is sensitive to the degree of denervationAnupom Borah, Kochupurackal P MohanakumarJournal of Pineal Research|December 17, 2003
Melatonin protects against oxidative stress caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the mouse nigrostriatumBobby Thomas, Kochupurackal P MohanakumarMedical Hypotheses|May 30, 2012
L-DOPA induced-endogenous 6-hydroxydopamine is the cause of aggravated dopaminergic neurodegeneration in Parkinson's disease patientsAnupom Borah, Kochupurackal P MohanakumarAging and Disease|April 27, 2016
Aging and Neurodegeneration: A Tangle of Models and MechanismsSasanka Chakrabarti, Kochupurackal P MohanakumarNeurochemistry International|August 15, 2015
Tea and Parkinson's disease: Constituents of tea synergize with antiparkinsonian drugs to provide better therapeutic benefitsDebashis Dutta, Kochupurackal P MohanakumarJournal of Pineal Research|October 3, 2009
Melatonin inhibits 6-hydroxydopamine production in the brain to protect against experimental parkinsonism in rodentsAnupom Borah, Kochupurackal P MohanakumarInternational Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|March 2, 2010
Early-life treatment of antiserotonin antibodies alters sensitivity to serotonin receptors, nociceptive stimulus and serotonin metabolism in adult ratsShravani Bhanja, Kochupurackal P MohanakumarBrain Research|May 18, 2010
Salicylic acid protects against chronic L-DOPA-induced 6-OHDA generation in experimental model of parkinsonismAnupom Borah, Kochupurackal P MohanakumarNeuroscience Letters|July 10, 2003
Calcium channel agonist, (+/-)-Bay K8644, causes an immediate increase in the striatal 1-methyl-4-phenylpyridinium level following systemic administration of the dopaminergic neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, in Balb/c miceSupriti Samantaray, Kochupurackal P MohanakumarCellular and Molecular Neurobiology|October 16, 2007
Long-term L-DOPA treatment causes indiscriminate increase in dopamine levels at the cost of serotonin synthesis in discrete brain regions of ratsAnupom Borah, Kochupurackal P MohanakumarPageof 7